News
Building in Houston expands Eli Lilly’s United States production at a time when its competitor, Novo Nordisk, maker of ...
1hon MSN
Prediction: After a Tough Summer for Healthcare Stocks, These 2 Companies Can Make a Comeback
One of them is already a leader in the market for weight management drugs, and the other could join this field.
A federal appeals court on Thursday rejected Eli Lilly's appeal of an $183.7 million judgment won by a whistleblowing lawyer ...
Eli Lilly (LLY) stock in focus as a federal appeals court upholds a lower court ruling which ordered the company to pay ...
Office cluster with Takeda HQ refinances for $1.3B Lilly’s latest $1B+ obesity deal is with Boston biotech Lilly’s latest ...
The United States Court of Appeals for the Seventh Circuit has affirmed a landmark jury verdict against pharmaceutical titan Eli Lilly on Thursday, forcing ...
4h
TipRanks on MSNEli Lilly’s Phase 1 Study of LY3985297: Key Insights for Investors
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company recently completed a ...
The deal includes AI-powered software for detecting known side effects of recently launched Alzheimer’s drugs.
In recent years, Lilly's top line has been growing at a much faster pace thanks to its already approved GLP-1 injections, ...
A $193 million award against Eli Lilly and Co. in a False Claims Act suit alleging Medicaid fraud will stand, the Seventh Circuit ruled Thursday.
Baxdrostat, a selective aldosterone synthase inhibitor, lowered BP and albuminuria in patients with uncontrolled hypertension ...
The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results